| Literature DB >> 33991091 |
Koen Bolhuis1,2, Ulla Lång1, David Gyllenberg3,4,5, Antti Kääriälä5, Juha Veijola6,7, Mika Gissler3,5,8, Ian Kelleher1,9,10.
Abstract
Expanding clinical strategies to identify high risk groups for psychotic and bipolar disorders is a research priority. Considering that individuals diagnosed with psychotic and bipolar disorder are at high risk of self-harm, we hypothesised the reverse order relationship would also be true (ie, self-harm would predict psychotic/bipolar disorder). Specifically, we hypothesised that hospital presentation for self-harm would be a marker of high risk for subsequent development of psychotic/bipolar disorder and sought to test this hypothesis in a large population sample. This prospective register-based study included everyone born in Finland in 1987, followed until age 28 years (N = 59 476). We identified all hospital records of self-harm presentations, as well as all ICD-10 healthcare registrations of first diagnoses of psychotic and bipolar disorders. Cox proportional hazards models were used to assess the relationship between self-harm and psychotic/bipolar disorders. Of all individuals who presented to hospital with self-harm (n = 481), 12.8% went on to receive a diagnosis of psychosis (hazard ratio [HR] = 6.03, 95% confidence interval [CI] 4.56-7.98) and 9.4% a diagnosis of bipolar disorder (HR = 7.85, 95% CI 5.73-10.76) by age 28 years. Younger age of first self-harm presentation was associated with higher risk-for individuals who presented before age 18 years, 29.1% developed a psychotic or bipolar disorder by age 28 years. Young people who present to hospital with self-harm are at high risk of future psychotic and bipolar disorders. They represent an important cohort for the prevention of serious mental illness.Entities:
Keywords: bidirectional; mania/epidemiology; register; schizophrenia; suicide
Mesh:
Year: 2021 PMID: 33991091 PMCID: PMC8530384 DOI: 10.1093/schbul/sbab061
Source DB: PubMed Journal: Schizophr Bull ISSN: 0586-7614 Impact factor: 9.306
Fig. 1.Kaplan-Meier cumulative incidence curves for the eight individual outcomes.
Bidirectional Associations Between Self-Harm and Serious Mental Illness Diagnosis
| (A) Self-Harm to Subsequent Psychotic/Bipolar Disorder | ||||||
|---|---|---|---|---|---|---|
| Overall Population | Females | Males | ||||
| Outcome Diagnosis |
| HR (95% CI) |
| HR (95% CI) |
| HR (95% CI) |
| Any psychotic or bipolar disorder | 66 (17.7) | 6.45 (5.05–8.25) | 44 (22.5) | 7.69 (5.68–10.40) | 22 (12.4) | 4.84 (3.17–7.39) |
| Any psychotic disorder | 51 (12.8) | 6.03 (4.56–7.98) | 32 (15.0) | 7.18 (5.03–10.24) | 19 (10.3) | 4.76 (3.02–7.51) |
| - Schizophrenia | 17 (3.7) | 6.71 (4.12–10.94) | 8 (3.2) | 7.14 (3.49–14.60) | 9 (4.2) | 6.57 (3.36–12.84) |
| - Other non-affective psychosis | 39 (9.1) | 5.20 (3.78–7.16) | 26 (11.1) | 6.90 (4.65–10.25) | 13 (6.7) | 3.54 (2.04–6.14) |
| - Affective psychosis | 35 (7.9) | 9.66 (6.85–13.62) | 22 (9.4) | 9.33 (6.05–14.41) | 13 (6.3) | 9.81 (5.59–17.23) |
| Any bipolar disorder | 41 (9.4) | 7.85 (5.73–10.76) | 32 (13.9) | 8.82 (6.17–12.63) | 9 (4.4) | 5.41 (2.78–10.53) |
| - Without psychotic features | 40 (9.1) | 7.93 (5.76–10.91) | 31 (13.4) | 8.77 (6.10–12.63) | 9 (4.3) | 5.71 (2.93–11.12) |
| - With psychotic features | 9 (1.9) | 8.65 (4.40–17.03) | 8 (3.1) | 12.08 (5.81–25.10) | 1 (0.5) | 2.53 (0.35–18.28) |
| (B) Psychotic/Bipolar Disorder to Subsequent Self-Harm | ||||||
| Overall Population | Females | Males | ||||
| Exposure Diagnosis |
| HR (95% CI) |
| HR (95% CI) |
| HR (95% CI) |
| Any psychotic or bipolar disorder | 107 (5.8) | 17.58 (14.59–21.18) | 65 (6.5) | 19.96 (15.60–25.52) | 42 (5.0) | 14.57 (10.89–19.49) |
| Any psychotic disorder | 83 (6.0) | 16.18 (13.26–19.75) | 48 (7.1) | 18.41 (14.15–23.95) | 35 (4.9) | 13.74 (10.10–18.68) |
| - Schizophrenia | 16 (5.0) | 13.39 (9.40–19.07) | 11 (8.2) | 16.86 (10.57–26.89) | 5 (2.7) | 10.80 (6.29–18.56) |
| - Other non-affective psychosis | 54 (5.1) | 13.34 (10.64–16.73) | 27 (5.6) | 15.03 (11.12–20.32) | 27 (4.7) | 11.77 (8.36–16.59) |
| - Affective psychosis | 40 (8.0) | 21.57 (16.86–27.59) | 28 (9.1) | 22.00 (16.17–29.95) | 12 (6.2) | 19.75 (13.02–29.95) |
| Any bipolar disorder | 43 (5.9) | 17.09 (13.50–21.63) | 30 (6.1) | 17.94 (13.49–23.86) | 13 (5.4) | 14.39 (9.26–22.36) |
| - Without psychotic features | 42 (6.0) | 17.21 (13.57–21.82) | 30 (6.3) | 18.02 (13.53–24.00) | 12 (5.3) | 14.48 (9.23–22.70) |
| - With psychotic features | 7 (5.5) | 15.95 (9.69–26.26) | 4 (5.4) | 18.34 (10.28–23.73) | 3 (5.6) | 10.81 (4.02–29.07) |
Note: Panel A: prospective relationships of self-harm (exposure) with subsequent psychotic and bipolar disorders (outcome); and Panel B: Prospective relationships of psychotic and bipolar disorder (exposure) with subsequent self-harm (outcome).
aThe percentages reflect the proportion of individuals with exposure diagnosis who were subsequently diagnosed with an outcome diagnosis, for example, 17 out of 465 (3.7%) individuals with self-harm were later diagnosed with schizophrenia (NB: individuals with a first diagnosis of schizophrenia before a first presentation with self-harm were excluded). Abbreviations: CI, confidence intervals; HR, hazard ratio.
Association of Self-Harm (Exposure) with Subsequent Psychotic and Bipolar Disorders (Outcome), Stratified by Age at First Self-Harm
| Total Population | Females | Males | ||||
|---|---|---|---|---|---|---|
|
| HR (95% CI) |
| HR (95% CI) |
| HR (95% CI) | |
|
| ||||||
| <18 years | 25 (29.1) | 12.43 (8.37–18.44) | 21 (33.9) | 13.38 (8.68–20.62) | 4 (16.7) | 7.42 (2.78–19.81) |
| 18–21 years | 22 (20.8) | 8.13 (5.34–12.39) | 14 (23.7) | 8.50 (5.01–14.41) | 8 (17.0) | 7.31 (3.65–14.68) |
| >21 years | 19 (10.4) | 3.45 (2.19–5.42) | 9 (12.00) | 3.59 (1.86–6.93) | 10 (9.4) | 3.43 (1.84–6.40) |
|
| ||||||
| <18 years | 19 (21.4) | 11.74 (7.46–18.47) | 15 (24.2) | 12.89 (7.73–21.51) | 4 (16.8) | 8.78 (3.29–23.47) |
| 18–21 years | 16 (12.0) | 7.03 (4.30–11.52) | 10 (15.9) | 7.73 (4.14–14.44) | 6 (12.5) | 6.12 (2.74–13.67) |
| >21 years | 16 (6.2) | 3.51 (2.14–5.75) | 7 (8.0) | 3.50 (1.66–7.37) | 9 (8.0) | 3.52 (1.82–6.79) |
|
| ||||||
| < 18 years | 9 (10.1) | 19.90 (10.26–38.63) | 8 (12.5) | 30.19 (14.76–61.73) | 1 (4.0) | 6.62 (0.93–47.27) |
| 18–21 years | 1 (0.8) | 1.45 (0.20–10.31) | 0 (0.0) | NA | 1 (1.8) | 2.89 (0.40–20.59) |
| > 21 years | 7 (2.8) | 5.04 (2.38–10.66) | 0 (0.0) | NA | 7 (5.2) | 8.03 (3.77–17.08) |
|
| ||||||
| <18 years | 13 (14.9) | 9.14 (5.29–15.80) | 10 (15.9) | 10.4 (5.57–19.49) | 4 (12.5) | 7.27 (2.34–22.60) |
| 18–21 years | 14 (11.6) | 6.90 (4.07–11.70) | 8 (11.3) | 7.28 (3.62–14.65) | 6 (12.0) | 6.66 (2.98–14.89) |
| >21 years | 12 (5.5) | 2.97 (1.68–5.24) | 8 (8.00) | 4.68 (2.33–9.42) | 3 (3.4) | 1.70 (0.63–4.54) |
|
| ||||||
| <18 years | 11 (12.6) | 16.54 (9.09–30.07) | 10 (16.1) | 17.29 (9.20–32.49) | 1 (4.0) | 6.53 (0.92–46.64) |
| 18–21 years | 10 (8.2) | 10.34 (5.53–19.35) | 6 (8.8) | 8.87 (3.95–19.92) | 4 (7.4) | 12.36 (4.59–33.28) |
| >21 years | 14 (6.0) | 7.03 (4.13–11.97) | 6 (5.8) | 5.44 (2.43–12.22) | 8 (6.2) | 9.43 (4.65–19.15) |
|
| ||||||
| <18 years | 14 (15.7) | 14.18 (8.35–24.06) | 13 (20.3) | 13.66 (7.87–23.71) | 1 (4.0) | 5.29 (0.74–37.75) |
| 18–21 years | 17 (13.8) | 12.57 (7.77–20.33) | 14 (20.0) | 13.84 (8.13–23.56) | 3 (5.7) | 7.57 (2.42–23.63) |
| >21 years | 10 (4.4) | 3.47 (1.86–6.48) | 5 (5.2) | 3.01 (1.25–7.26) | 5 (3.9) | 4.63 (1.91–11.24) |
|
| ||||||
| <18 years | 13 (14.6) | 13.65 (7.89–23.64) | 12 (18.8) | 12.94 (7.29–22.95) | 1 (4.0) | 5.62 (0.79–40.05) |
| 18–21 years | 17 (13.8) | 13.02 (8.05–21.08) | 14 (20.0) | 14.20 (8.94–24.17) | 3 (5.7) | 8.02 (2.57–25.07) |
| >21 years | 10 (4.4) | 3.59 (1.92–6.70) | 5 (5.2) | 3.09 (1.28–7.46) | 5 (3.9) | 4.88 (2.01–11.84) |
|
| ||||||
| <18 years | 2 (2.3) | 10.28 (2.54–42.56) | 2 (3.1) | 12.00 (2.94–48.94) | 0 (0.0) | NA |
| 18–21 years | 2 (1.5) | 7.23 (1.79–29.24) | 2 (2.6) | 10.56 (2.59–43.06) | 0 (0.0) | NA |
| >21 years | 5 (2.0) | 8.79 (3.59–21.50) | 4 (3.4) | 13.06 (4.77–35.77) | 1 (0.7) | 3.91 (0.54–28.29) |
Note: Reference group is individuals who did not present with self-injurious behaviour. Individuals with a first diagnosis of the respective outcome diagnosis before a first presentation with self-harm were excluded. Abbreviations: CI, confidence intervals; HR, hazard ratio.
Association of Self-Harm (Exposure) With Subsequent Psychotic and Bipolar Disorders (Outcome), Stratified Number of Self-Harm Presentations
| Total Population | Females | Males | ||||
|---|---|---|---|---|---|---|
|
| HR (95% CI) |
| HR (95% CI) |
| HR (95% CI) | |
|
| ||||||
| Single | 41 (16.0) | 6.16 (4.52–8.39) | 25 (20.0) | 6.91(4.65–10.29) | 16 (13.1) | 5.25 (3.20–8.62) |
| Multiple | 25 (19.7) | 7.01 (4.72–10.40) | 19 (26.8) | 9.02 (5.73–14.21) | 6 (10.7) | 3.99 (1.79–8.92) |
|
| ||||||
| Single | 29 (11.2) | 5.28 (3.65–7.62) | 15 (11.2) | 5.34 (3.20–8.91) | 14 (11.11) | 5.22 (3.07–8.86) |
| Multiple | 22 (15.9) | 7.44 (4.88–11.35) | 17 (21.5) | 10.31 (6.37–16.69) | 5 (8.5) | 3.82 (1.58–9.20) |
|
| ||||||
| Single | 8 (2.7) | 5.00 (2.48–10.09) | 3 (2.0) | 4.40 (1.40–13.84) | 5 (3.5) | 5.55 (2.28–13.49) |
| Multiple | 9 (5..3) | 9.66 (4.98–18.75) | 5 (5.2) | 11.39 (4.66–27.85) | 4 (5.6) | 8.55 (3.17–23.03) |
|
| ||||||
| Single | 22 (8.0) | 4.60 (3.01–7.02) | 13 (9.0) | 5.65 (3.26–9.81) | 9 (6.9) | 3.65 (1.89–7.06) |
| Multiple | 17 (11.3) | 6.27 (3.88–10.13) | 13 (14.) | 8.86 (5.11–15.38) | 4 (6.5) | 3.31 (1.24–8.85) |
|
| ||||||
| Single | 19 (6.8) | 8.28 (5.24–13.10) | 10 (7.0) | 6.98 (3.71–13.11) | 9 (6.5) | 10.27 (5.26–20.06) |
| Multiple | 16 (10.0) | 12.04 (7.32–19.82) | 12 (13.2) | 12.99 (7.29–23.15) | 4 (5.8) | 8.92 (3.31–24.01) |
|
| ||||||
| Single | 26 (9.1) | 7.76 (5.25–11.48) | 19 (14.2) | 8.48 (5.36–13.42) | 7 (5.0) | 6.31 (2.98–13.39) |
| Multiple | 15 (9.8) | 8.02 (4.81–13.38) | 13 (14.9) | 9.38 (5.40–16.27 | 2 (3.0) | 3.60 (0.90–14.49) |
|
| ||||||
| Single | 26 (9.1) | 8.05 (5.44–11.91) | 19 (13.2) | 8.71 (5.50–13.78) | 7 (5.0) | 6.69 (3.15–14.21) |
| Multiple | 14 (9.1) | 7.72 (4.55–13.11) | 12 (13.8) | 8.89 (5.01–15.76) | 2 (3.0) | 3.77 (0.94–15.15) |
|
| ||||||
| Single | 3 (1.0) | 4.56 (1.45–14.34) | 2 (1.3) | 5.00 (1.23–20.39) | 1 (0.7) | 3.79 (0.52–27.42) |
| Multiple | 3 (3.5) | 15.69 (6.91–35.62) | 6 (5.9) | 22.87 (9.94–52.66) | 0 (0.0) | NA |
Note: Reference group is individuals who did not present with self-injurious behaviour. Individuals with a first diagnosis of the respective outcome diagnosis before a first presentation with self-harm were excluded. Abbreviations: CI, confidence intervals; HR, hazard ratio.
Association of Self-Harm (Exposure) With Subsequent Psychotic and Bipolar Disorders (Outcome), Stratified by Method of Self-Harm
| Total Population | Females | Males | ||||
|---|---|---|---|---|---|---|
|
| HR (95% CI) |
| HR (95% CI) |
| HR (95% CI) | |
|
| ||||||
| Self-poisoning | 53 (17.3) | 6.32 (4.81–8.30) | 36 (21.3) | 7.25 (5.20–10.11) | 17 (12.4) | 4.84 (2.99–7.82) |
| Other | 13 (19.1) | 7.09 (4.11–12.24) | 8 (29.6) | 10.57 (5.27–21.21) | 5 (12.2) | 4.84 (2.01–11.65) |
|
| ||||||
| Self-poisoning | 41 (12.6) | 5.92 (3.34–8.07) | 26 (14.2) | 6.80 (4.59–10.06) | 15 (10.6) | 4.84 (2.90–8.07) |
| Other | 10 (13.7) | 6.57 (3.53–12.24) | 6 (20.0) | 9.50 (4.25–21.22) | 4 (9.3) | 4.48 (1.68–11.97) |
|
| ||||||
| Self-poisoning | 12 (3.2) | 5.79 (3.23–10.25) | 6 (2.8) | 6.20 (2.73–14.07) | 6 (3.6) | 5.65 (2.50–12.74) |
| Other | 5 (6.0) | 11.16 (4.61–27.02) | 2 (5.9) | 13.06 (3.23–52.81) | 3 (6.0) | 12.77 (3.12–30.58) |
|
| ||||||
| Self-poisoning | 34 (9.7) | 5.53 (3.93–7.78) | 22 (10.9) | 6.81 (4.44–10.45) | 12 (8.1) | 4.21 (2.37–7.45) |
| Other | 5 (6.6) | 3.72 (1.55–8.96) | 4 (12.5) | 7.44 (2.78–19.90) | 1 (2.3) | 1.22 (0.17–8.68) |
|
| ||||||
| Self-poisoning | 27 (7.5) | 9.07 (6.15–13.36) | 18 (9.0) | 8.85 (5.50–14.26) | 9 (5.7) | 8.74 (4.48–17.08) |
| Other | 8 (9.9) | 12.41 (6.19–24.97) | 4 (12.5) | 12.37 (4.61–33.19) | 4 (8.2) | 13.54 (5.03–36.45) |
|
| ||||||
| Self-poisoning | 34 (9.5) | 7.98 (5.66–11.26) | 26 (13.1) | 8.29 (5.58–12.30) | 8 (5.1) | 6.29 (3.11–12.73) |
| Other | 7 (8.6) | 7.29 (3.46–15.35) | 6 (18.8) | 12.28 (5.49–27.48) | 1 (2.0) | 2.55 (0.36–18.17) |
|
| ||||||
| Self-poisoning | 33 (9.2) | 8.01 (5.65–11.37) | 12 (12.6) | 8.18 (5.47–12.23) | 8 (5.0) | 6.63 (3.27–13.42) |
| Other | 7 (8.6) | 7.57 (3.59–15.93) | 6 (18.8) | 12.61 (5.63–28.21) | 1 (2.0) | 2.70 (0.38–19.29) |
|
| ||||||
| Self-poisoning | 9 (2.3) | 10.59 (5.38–20.85) | 8 (3.6) | 14.15 (6.81–29.40) | 1 (0.6) | 3.26 (0.45–23.62) |
| Other | 0 (0.0) | NA | 0 (0.0) | NA | 0 (0.0) | NA |
Note: Reference group is individuals who did not present with self-injurious behaviour. Individuals with a first diagnosis of the respective outcome diagnosis before a first presentation with self-harm were excluded. Abbreviations: CI, confidence intervals; HR, hazard ratio.